A multicenter randomized controlled study to evaluate the effectiveness to share monitoring of daily symptoms between patients and physicians in the treatment of Parkinson's disease

A multicenter randomized controlled study to evaluate the effectiveness to share monitoring of daily symptoms between patients and physicians in the treatment of Parkinson's disease - SHARE-PD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047860

Enrollment

110

Registered

2022-05-25

Start date

2022-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Using a wearable device, a smartphone and its application during the 6-month Regular medical care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The participant has been diagnosed with Parkinson's disease on the basis of the International Parkinson and Movement Disorder Society (MDS) and has motor/non-motor symptoms that require clinically complex management. 2. The participant is capable of operating each device used in this study, and understanding and complying with protocol requirements, in the opinion of the investigator. 3. The participant signs and dates a written, informed consent form prior to the initiation of any study procedures. 4. The participant is aged 20 years or older at the time of informed consent. 5. The participant is capable of visiting the outpatient clinic during the evaluation period.

Exclusion criteria

Exclusion criteria: 1. The participant has metal allergy. 2. The participant has cognitive impairment that, in the opinion of the investigator, would interfere with the ability to report on symptoms and function. 3. The participant has unstable Parkinson's disease and comorbidities that would make outpatient visits difficult, in the opinion of the investigator. 4. The participant is judged by the investigator as being ineligible for any other reason.

Design outcomes

Primary

Measure	Time frame
MDS-UPDRS Total Score	—

Countries

Japan

Contacts

Public ContactMiwa Izutsu

Takeda Pharmaceutical Company Limited Japan Medical Office

miwa.izutsu@takeda.com03-3278-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

A multicenter randomized controlled study to evaluate the effectiveness to share monitoring of daily symptoms between patients and physicians in the treatment of Parkinson&#39;s disease